US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 125.050
  • +1.830+1.49%
Trading Jan 24 12:06 ET
216.89BMarket Cap16.37P/E (TTM)

Abbott Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
4.59%41.95B
7.16%10.97B
4.85%10.64B
4.00%10.38B
2.23%9.96B
-8.12%40.11B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
Operating revenue
4.59%41.95B
7.16%10.97B
4.85%10.64B
4.00%10.38B
2.23%9.96B
-8.12%40.11B
1.49%10.24B
-2.56%10.14B
-11.36%9.98B
-18.06%9.75B
Cost of revenue
4.07%18.71B
8.47%4.94B
2.02%4.7B
2.68%4.6B
3.05%4.46B
-6.10%17.98B
-0.81%4.56B
-0.52%4.61B
-9.12%4.48B
-13.15%4.33B
Gross profit
5.01%23.24B
6.10%6.03B
7.20%5.94B
5.08%5.77B
1.57%5.5B
-9.70%22.13B
3.40%5.69B
-4.20%5.54B
-13.11%5.5B
-21.60%5.42B
Operating expense
4.87%16.42B
5.53%4.12B
4.81%4.08B
3.85%4.11B
5.32%4.12B
-3.05%15.66B
-6.89%3.91B
-2.99%3.89B
0.13%3.95B
-2.23%3.91B
Selling and administrative expenses
6.83%11.7B
6.72%2.91B
6.32%2.9B
7.15%2.94B
7.13%2.96B
-2.66%10.95B
-8.38%2.72B
-0.29%2.72B
-0.62%2.74B
-0.90%2.76B
Research and development costs
3.76%2.84B
7.00%749M
6.10%713M
-2.38%698M
4.59%684M
-5.09%2.74B
-3.45%700M
-14.07%672M
4.53%715M
-6.17%654M
Depreciation amortization depletion
-4.48%1.88B
-3.33%465M
-5.24%470M
-5.42%471M
-3.87%472M
-2.33%1.97B
-3.02%481M
-0.40%496M
-1.78%498M
-4.10%491M
-Depreciation and amortization
-4.48%1.88B
-3.33%465M
-5.24%470M
-5.42%471M
-3.87%472M
-2.33%1.97B
-3.02%481M
-0.40%496M
-1.78%498M
-4.10%491M
Operating profit
5.36%6.83B
7.36%1.91B
12.87%1.86B
8.24%1.67B
-8.15%1.39B
-22.53%6.48B
36.50%1.78B
-6.95%1.65B
-35.10%1.54B
-48.18%1.51B
Net non-operating interest income expense
14.68%-215M
35.71%-45M
26.09%-51M
4.92%-58M
-17.31%-61M
32.80%-252M
-6.06%-70M
19.77%-69M
42.45%-61M
55.56%-52M
Non-operating interest income
----
----
-6.19%91M
-16.33%82M
-20.79%80M
110.38%385M
1.14%89M
76.36%97M
276.92%98M
621.43%101M
Non-operating interest expense
-66.25%215M
-71.70%45M
-14.46%142M
-11.95%140M
-7.84%141M
14.16%637M
3.25%159M
17.73%166M
20.45%159M
16.79%153M
Other net income (expense)
-7.99%403M
92.94%164M
41.94%132M
-102.58%-4M
5.71%111M
37.30%438M
3.66%85M
25.68%93M
89.02%155M
29.63%105M
Gain on sale of security
165.85%27M
141.67%10M
10.00%11M
128.57%6M
----
-1,950.00%-41M
-271.43%-24M
152.63%10M
---21M
-300.00%-6M
Other non- operating income (expenses)
-21.50%376M
41.28%154M
45.78%121M
-105.68%-10M
0.00%111M
49.22%479M
60.29%109M
-10.75%83M
114.63%176M
42.31%111M
Income before tax
5.24%7.01B
13.09%2.03B
16.10%1.94B
-1.77%1.61B
-8.07%1.44B
-19.77%6.66B
35.98%1.8B
-4.95%1.67B
-30.44%1.64B
-45.69%1.56B
Income tax
-778.96%-6.39B
-3,681.59%-7.2B
25.11%294M
16.86%305M
-13.52%211M
-31.46%941M
-29.97%201M
-27.24%235M
-21.86%261M
-43.12%244M
Net income
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
Net income continuous Operations
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
Minority interest income
Net income attributable to the parent company
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
-17.45%5.72B
54.31%1.59B
0.07%1.44B
-31.86%1.38B
-46.14%1.32B
Basic earnings per share
135.58%7.7269
478.86%5.321
14.63%0.94
-6.33%0.74
-6.67%0.7
-16.75%3.28
54.64%0.9192
0.00%0.82
-31.30%0.79
-45.65%0.75
Diluted earnings per share
134.36%7.64
479.12%5.27
14.63%0.94
-5.13%0.74
-6.67%0.7
-16.62%3.26
54.24%0.91
1.23%0.82
-31.58%0.78
-45.26%0.75
Dividend per share
7.84%2.2
7.84%0.55
7.84%0.55
7.84%0.55
7.84%0.55
8.51%2.04
8.51%0.51
8.51%0.51
8.51%0.51
8.51%0.51
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 4.59%41.95B7.16%10.97B4.85%10.64B4.00%10.38B2.23%9.96B-8.12%40.11B1.49%10.24B-2.56%10.14B-11.36%9.98B-18.06%9.75B
Operating revenue 4.59%41.95B7.16%10.97B4.85%10.64B4.00%10.38B2.23%9.96B-8.12%40.11B1.49%10.24B-2.56%10.14B-11.36%9.98B-18.06%9.75B
Cost of revenue 4.07%18.71B8.47%4.94B2.02%4.7B2.68%4.6B3.05%4.46B-6.10%17.98B-0.81%4.56B-0.52%4.61B-9.12%4.48B-13.15%4.33B
Gross profit 5.01%23.24B6.10%6.03B7.20%5.94B5.08%5.77B1.57%5.5B-9.70%22.13B3.40%5.69B-4.20%5.54B-13.11%5.5B-21.60%5.42B
Operating expense 4.87%16.42B5.53%4.12B4.81%4.08B3.85%4.11B5.32%4.12B-3.05%15.66B-6.89%3.91B-2.99%3.89B0.13%3.95B-2.23%3.91B
Selling and administrative expenses 6.83%11.7B6.72%2.91B6.32%2.9B7.15%2.94B7.13%2.96B-2.66%10.95B-8.38%2.72B-0.29%2.72B-0.62%2.74B-0.90%2.76B
Research and development costs 3.76%2.84B7.00%749M6.10%713M-2.38%698M4.59%684M-5.09%2.74B-3.45%700M-14.07%672M4.53%715M-6.17%654M
Depreciation amortization depletion -4.48%1.88B-3.33%465M-5.24%470M-5.42%471M-3.87%472M-2.33%1.97B-3.02%481M-0.40%496M-1.78%498M-4.10%491M
-Depreciation and amortization -4.48%1.88B-3.33%465M-5.24%470M-5.42%471M-3.87%472M-2.33%1.97B-3.02%481M-0.40%496M-1.78%498M-4.10%491M
Operating profit 5.36%6.83B7.36%1.91B12.87%1.86B8.24%1.67B-8.15%1.39B-22.53%6.48B36.50%1.78B-6.95%1.65B-35.10%1.54B-48.18%1.51B
Net non-operating interest income expense 14.68%-215M35.71%-45M26.09%-51M4.92%-58M-17.31%-61M32.80%-252M-6.06%-70M19.77%-69M42.45%-61M55.56%-52M
Non-operating interest income ---------6.19%91M-16.33%82M-20.79%80M110.38%385M1.14%89M76.36%97M276.92%98M621.43%101M
Non-operating interest expense -66.25%215M-71.70%45M-14.46%142M-11.95%140M-7.84%141M14.16%637M3.25%159M17.73%166M20.45%159M16.79%153M
Other net income (expense) -7.99%403M92.94%164M41.94%132M-102.58%-4M5.71%111M37.30%438M3.66%85M25.68%93M89.02%155M29.63%105M
Gain on sale of security 165.85%27M141.67%10M10.00%11M128.57%6M-----1,950.00%-41M-271.43%-24M152.63%10M---21M-300.00%-6M
Other non- operating income (expenses) -21.50%376M41.28%154M45.78%121M-105.68%-10M0.00%111M49.22%479M60.29%109M-10.75%83M114.63%176M42.31%111M
Income before tax 5.24%7.01B13.09%2.03B16.10%1.94B-1.77%1.61B-8.07%1.44B-19.77%6.66B35.98%1.8B-4.95%1.67B-30.44%1.64B-45.69%1.56B
Income tax -778.96%-6.39B-3,681.59%-7.2B25.11%294M16.86%305M-13.52%211M-31.46%941M-29.97%201M-27.24%235M-21.86%261M-43.12%244M
Net income 134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B
Net income continuous Operations 134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B
Minority interest income
Net income attributable to the parent company 134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B-17.45%5.72B54.31%1.59B0.07%1.44B-31.86%1.38B-46.14%1.32B
Basic earnings per share 135.58%7.7269478.86%5.32114.63%0.94-6.33%0.74-6.67%0.7-16.75%3.2854.64%0.91920.00%0.82-31.30%0.79-45.65%0.75
Diluted earnings per share 134.36%7.64479.12%5.2714.63%0.94-5.13%0.74-6.67%0.7-16.62%3.2654.24%0.911.23%0.82-31.58%0.78-45.26%0.75
Dividend per share 7.84%2.27.84%0.557.84%0.557.84%0.557.84%0.558.51%2.048.51%0.518.51%0.518.51%0.518.51%0.51
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Cipher Mining
CIFR
+10.71%
TeraWulf
WULF
+7.61%
BTCS Inc
BTCS
+6.80%
Riot Platforms
RIOT
+6.55%
Hut 8
HUT
+5.19%

Unlock the Full List

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+0.75%
Infectious Disease
Infectious Disease
Intraday+0.34%